Question 1

What is the catalog number for 2-Methylresorcinol 99+%?

Accepted Answer

The catalog number for 2-Methylresorcinol 99+% is 230585.

Question 2

What sizes are available for 2-Methylresorcinol 99+%?

Accepted Answer

2-Methylresorcinol 99+% is available in the following size(s): 25 g, 100 g, 250 g, 1 Kg, 5 Kg.

Question 3

How many pack sizes does 2-Methylresorcinol 99+% come in?

Accepted Answer

2-Methylresorcinol 99+% is available in 5 different pack sizes.

Question 4

Is 2-Methylresorcinol 99+% in stock?

Accepted Answer

2-Methylresorcinol 99+% is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

2-Methylresorcinol 99+%

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

UBE2H (Ubiquitin-conjugating Enzyme E2 H, UbcH2, Ubiquitin Carrier Protein H, UBCH, Ubiquitin-conjugating Enzyme E2-20K, Ubiquitin-protein Ligase H) (MaxLight 550)

UBE2H (Ubiquitin-conjugating Enzyme E2 H, UbcH2, Ubiquitin Carrier Protein H, UBCH, Ubiquitin-conjugating Enzyme E2-20K, Ubiquitin-protein Ligase H) (MaxLight 550)

NPL Antibody Blocking Peptide

Anti-human TFPI (Concizumab Biosimilar)

Anti-human TFPI (Concizumab Biosimilar)

Anti-human TFPI (Concizumab Biosimilar)